[3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxy-2-[(8Z,11Z,14Z)-nonadeca-8,11,14-trienoyl]oxypropyl] (8Z,11Z,14Z)-icosa-8,11,14-trienoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 甘油脂
• 英文名称: [3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxy-2-[(8Z,11Z,14Z)-nonadeca-8,11,14-trienoyl]oxypropyl] (8Z,11Z,14Z)-icosa-8,11,14-trienoate
• 化学式: C₆₂H₁₀₂O₆
• 分子量: 943.5
• InChiKey: NDBLKICZUDQFGV-XSCDNRTKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  21
• 重原子数：
  68
• 可旋转键数：
  52
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.66
• 拓扑面积：
  78.9
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• USE OF PUFAS FOR TREATING SKIN INFLAMMATION
  申请人：Dignity Sciences Limited

  公开号：US20140194399A1

  公开（公告）日：2014-07-10

  The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
• TOPICAL COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACIDS
  申请人：DS Biopharma Limited

  公开号：US20180116991A1

  公开（公告）日：2018-05-03

  The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.